Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Kern | History Defined

Lorena Wiebes' bike weight disqualification: How did it happen, what happens next, and who's to blame? Here's everything we know

Answering all the questions surrounding the UCI's shock ruling

Astell & Kern's premium portable player is the first of its kind to personalise its sound to your ears

Astell & Kern's premium portable player is the first of its kind to personalise its sound to your ears

Your sound, your way

Astell&Kern shoots for the moon with its luxury Luna IEMs

Astell&Kern shoots for the moon with its luxury Luna IEMs

Astell&Kern introduces a new planar magnetic driver with its Luna in-ears that promises stellar sound.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Food waste in the EU vs. the U.S.

"In April 2023, ReFed . . . reported that the amount of uneaten food in the U.S. has grown 4.8% since 2016"

Rewind: High End hi-fi highlights from Sonus Faber, Q Acoustics, Astell & Kern and more

Struggling to keep on top of all the hi-fi and home cinema news from last week? There’s a good reason for that.

Akerna Reports Software Revenue Increase Of 40% YTD, Double-Digit YoY Growth For Q3

Akerna (NASDAQ: KERN) reported on Monday its unaudited financial results for the third quarter, which ended September 30, 2022.

Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session

Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.

inkl

Read news from The Economist, FT, and more,
with one subscription

Akerna Closes $10M Public Offering

Akerna Closes $10M Public Offering

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.

Akerna Stock Plummets Following $10M Public Offering

Akerna Stock Plummets Following $10M Public Offering

Akerna Corp. (NASDAQ: KERN) announced the pricing of an underwritten public offering of 29.38 million units of the company consisting of 29.38 million shares of common stock together with common stock warran

Earnings Preview: Akerna

Earnings Preview: Akerna

Akerna (NASDAQ:KERN) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Akerna will report an earnings per share (EPS) of $-0.17.

Akerna Flash Report: 4/20 Cannabis Sales Reached $154.4M, Setting New Single-Day Sales Record

Akerna Flash Report: 4/20 Cannabis Sales Reached $154.4M, Setting New Single-Day Sales Record

Akerna (NASDAQ: KERN) announced that this year's 4/20 holiday broke all previous cannabis retail records, bringing in a total of $154.4 million in adult-use and medicinal sales.

Akerna Flash Predicts 420 To Bring In Over $130M In Legal Cannabis Sales; Will It Be The Largest Sales Day Ever?

Akerna Flash Predicts 420 To Bring In Over $130M In Legal Cannabis Sales; Will It Be The Largest Sales Day Ever?

Akerna (NASDAQ: KERN) predicts that U.S.

Akerna Reports 61% YoY Increase In Q4 Revenue, Wider Net Loss

Akerna Reports 61% YoY Increase In Q4 Revenue, Wider Net Loss

Akerna (NASDAQ:KERN) has reported its unaudited financial results for the quarter and year ended December 31, 2021.

Get all your
news in one place.

100's of premium titles.
One news app.

Preview: Akerna's Earnings

Akerna (NASDAQ:KERN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate that Akerna will report an earnings per share (EPS) of $-0.14.

What Do Women Want? Akerna's Report Reveals Top Marijuana Products Among Female Cannabis Shoppers

Akerna (NASDAQ: KERN) released a data report on women's cannabis shopping habits as the demographic group continues to gain market share, up 3.3% since 2019.

Akerna Releases 2021 Cannabis Report Highlighting Growth In Industry

It’s no secret that cannabis is a growing industry.

Cannabis Movers & Shakers: Akerna, iAnthus, Cronos Group, WSU's Cannabis Research Center

Akerna Taps Current COO Ray Thompson As President & COO Akerna Corp (NASDAQ: KERN) announced Thursday that it has appointed its current COO as its president and COO, effective immediately.

Get all your
news in one place.

100's of premium titles.
One news app.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

The European Union

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

380,819 stories

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play